These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1811547)

  • 1. Blood rheology and fibrinogen in children with familial hypercholesterolaemia.
    Jay RH; McCarthy SN; Rampling MW; Betteridge DJ
    Atherosclerosis; 1991 Nov; 91(1-2):117-21. PubMed ID: 1811547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormalities of blood rheology in familial hypercholesterolaemia: effects of treatment.
    Jay RH; Rampling MW; Betteridge DJ
    Atherosclerosis; 1990 Dec; 85(2-3):249-56. PubMed ID: 2129320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma thrombomodulin is not increased in familial hypercholesterolemic children with rheological alterations.
    Vayá A; Martínez M; Dalmau J; Martí R; Ballesta A; Aznar J
    Clin Hemorheol Microcirc; 1998 Oct; 19(2):133-8. PubMed ID: 9849926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks.
    Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P
    Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of LDL apheresis on blood rheology in two patients with homozygous familial hypercholesterolaemia.
    Fadul JE; Sandhagen B; Linde T; Vessby B; Wikström B; Danielson BG
    Blood Purif; 1997; 15(3):182-7. PubMed ID: 9262844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin improves blood rheology in patients with familial hypercholesterolemia (FH) on long-term LDL apheresis treatment.
    Banyai S; Banyai M; Falger J; Jansen M; Alt E; Derfler K; Koppensteiner R
    Atherosclerosis; 2001 Dec; 159(2):513-9. PubMed ID: 11730833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of lovastatin on hemorheology in type II hyperlipoproteinemia.
    Koppensteiner R; Minar E; Ehringer H
    Atherosclerosis; 1990 Jul; 83(1):53-8. PubMed ID: 2390136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lovastatin therapy in heterozygous familial hypercholesterolaemic patients: effect on blood rheology and fibrinogen levels.
    Beigel Y; Fuchs J; Snir M; Lurie Y; Green P; Djaldetti M
    J Intern Med; 1991 Jul; 230(1):23-7. PubMed ID: 2066708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations.
    Torres AL; Moorjani S; Vohl MC; Gagné C; Lamarche B; Brun LD; Lupien PJ; Després JP
    Atherosclerosis; 1996 Sep; 126(1):163-71. PubMed ID: 8879444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of HMG-CoA reductase inhibitors on red blood cell membrane lipids and haemorheological parameters, in patients affected by familial hypercholesterolemia.
    Martinez M; Vaya A; Marti R; Gil L; Lluch I; Carmena R; Aznar J
    Haemostasis; 1996 Oct; 26 Suppl 4():171-6. PubMed ID: 8979121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.
    Cummings MH; Watts GF; Umpleby M; Hennessy TR; Quiney JR; Sönksen PH
    Atherosclerosis; 1995 Feb; 113(1):79-89. PubMed ID: 7755658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carotid atherosclerosis and lipoprotein particle subclasses in familial hypercholesterolaemia and familial combined hyperlipidaemia.
    Jarauta E; Mateo-Gallego R; Gilabert R; Plana N; Junyent M; de Groot E; Cenarro A; Masana L; Ros E; Civeira F
    Nutr Metab Cardiovasc Dis; 2012 Jul; 22(7):591-7. PubMed ID: 21196102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocyte deformability in young familial hypercholesterolemics.
    Vayá A; Martínez M; Guillén M; Dalmau J; Aznar J
    Clin Hemorheol Microcirc; 1998 Sep; 19(1):43-8. PubMed ID: 9806733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of low density lipoprotein to oxidation in familial hypercholesterolaemia.
    Raal FJ; Areias AJ; Waisberg R; von Arb M
    Atherosclerosis; 1995 May; 115(1):9-15. PubMed ID: 7669091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute effects of extracorporeal LDL cholesterol and fibrinogen elimination on blood rheology and microcirculation].
    Kleophas W; Leschke M; Tschöpe D; Martin J; Schauseil S; Schottenfeld Y; Strauer BE; Gries FA
    Dtsch Med Wochenschr; 1990 Jan; 115(1):3-7. PubMed ID: 2295300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein profile assessed by 2D-1H-NMR and subclinical atherosclerosis in children with familial hypercholesterolaemia.
    Rodríguez-Borjabad C; Ibarretxe D; Girona J; Ferré R; Feliu A; Amigó N; Guijarro E; Masana L; Plana N;
    Atherosclerosis; 2018 Mar; 270():117-122. PubMed ID: 29407879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of raised low-density lipoprotein cholesterol in a patient with familial hypercholesterolaemia and lipoprotein lipase deficiency.
    Zambon A; Torres A; Bijvoet S; Gagne C; Moorjani S; Lupien PJ; Hayden MR; Brunzell JD
    Lancet; 1993 May; 341(8853):1119-21. PubMed ID: 8097805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased blood viscosity and fibrinolytic inhibitor in type II hyperlipoproteinaemia.
    Lowe GD; McArdle BM; Stromberg P; Lorimer AR; Forbes CD; Prentice CR
    Lancet; 1982 Feb; 1(8270):472-5. PubMed ID: 6121140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of buflomedil on blood viscosity parameters in insulin-dependent diabetic patients: a preliminary study.
    Van Acker K; Rillaerts E; De Leeuw I
    Biomed Pharmacother; 1989; 43(3):219-22. PubMed ID: 2775859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lovastatin alters blood rheology in primary hyperlipoproteinemia: dependence on lipoprotein(a)?
    Koenig W; Hehr R; Ditschuneit HH; Kuhn K; Ernst E; Rosenthal J; Hombach V
    J Clin Pharmacol; 1992 Jun; 32(6):539-45. PubMed ID: 1634641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.